SER SERINA THERAPEUTICS INC Management Changes 8-K Filing 2024 - Management Changes Agex Therapeutics appointed Gregory S. Curhan as Chief Financial Officer, effective August 16, 2024, while Andrea Park's employment as Interim CFO ended on August 15, 2024.Get access to all SEC 8-K filings of the SERINA THERAPEUTICS INC